Deldacan, Jana Mae A.
HRN: 29-02-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CEFTRIAXONE 1G (VIAL)
05/21/2026
05/28/2026
IV
2g
OD
CAPMR
Checking Initial Appropriateness
05/21/2026
AZITHROMYCIN 500MG TABLET (TAB)
05/21/2026
05/28/2026
PO
500mg
OD
CAPMR
Checking Initial Appropriateness
05/28/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/28/2026
06/04/2026
IVT
1.5g
Q6
Acinetobacter Iwoffii/haemolyticus
Checking Initial Appropriateness
06/02/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/02/2026
06/08/2026
IV
9gm
Q6
CAP MR Acinetobacter
Checking Initial Appropriateness
06/12/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/12/2026
06/18/2026
IV
9gms
Q6h
CAP MR Acinetobacter
Checking Initial Appropriateness